Moderna COVID-19 vaccine appears to work as well in older adults in early study

The analysis looked at subjects given the 100-microgram dose being tested in the much larger Phase III trial. Moderna said the immune responses in those aged between ages 56 and 70, above age 70 and those 18 to 55-years-old were similar.

Health officials have been concerned about whether vaccine candidates would work in older people, whose immune systems typically do not respond as strongly to vaccines.

The post Moderna COVID-19 vaccine appears to work as well in older adults in early study appeared first on CNBC Africa.

CNBC AFRICA
Source : African Media Agency (AMA)